Research
Hormonal
Dual agonists improve glycemic control and promote substantial weight loss.
Practitioners can consider dual agonists as effective options for improving glycemic control and aiding weight loss in patients with metabolic diseases.
StrongSupportsmedium confidence
The review explores how dual agonists improve glycemic control, promote substantial weight loss, and modify cardiometabolic risk factors.
Why this rating
The claim is supported by qualitative thematic evidence from major clinical trials.
Source
Emerging Role of Dual Agonists in Metabolic Disease Management: Clinical Outcomes and Safety Considerations – A Review Study
Akter Sraboni et al. · Review of Medicine Surgery and Dentistry · 2026
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →